Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes

Haematologica. 2024 Feb 1;109(2):666-670. doi: 10.3324/haematol.2023.283402.
No abstract available

MeSH terms

  • Humans
  • Mutation
  • Waldenstrom Macroglobulinemia* / drug therapy

Grants and funding

Funding: This work was supported by grants from the National Nature Science Foundation of China (81970187, 82170193, 81920108006, 81900203, 82200215), the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2022-I2M-1-022), Tianjin Health Science and Technology Project (TJWJ2022XK021), and Tianjin Health Research Project (TJSQNYXXR-D2-152).